The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Leiden Jeffrey M since 2015.
This trader's CIK number is 1242825.
At the time of last reporting, Leiden Jeffrey M was the Executive Chairman of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | DGX | 0 | $0 | 1,644 | $173,622 | 0 | $0 |
| 2017 | DGX | 0 | $0 | 1,600 | $173,353 | 0 | $0 |
| 2016 | DGX | 0 | $0 | 6,345 | $543,296 | 6,641 | $464,079 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VRTX | 0 | $0 | 73,292 | $32,326,217 | 73,292 | $6,551,823 |
| 2024 | VRTX | 0 | $0 | 16,188 | $7,088,643 | 0 | $0 |
| 2023 | VRTX | 0 | $0 | 39,278 | $14,730,919 | 0 | $0 |
| 2022 | VRTX | 0 | $0 | 147,868 | $41,728,833 | 60,342 | $5,494,139 |
| 2020 | VRTX | 0 | $0 | 385,661 | $104,088,650 | 265,603 | $35,260,125 |
| 2019 | VRTX | 0 | $0 | 469,566 | $88,333,562 | 416,319 | $41,422,804 |
| 2018 | VRTX | 0 | $0 | 239,774 | $38,129,667 | 206,063 | $13,549,833 |
| 2017 | VRTX | 0 | $0 | 680,892 | $94,200,506 | 482,572 | $19,960,765 |
| 2016 | VRTX | 0 | $0 | 9,834 | $899,201 | 0 | $0 |
| 2015 | VRTX | 0 | $0 | 64,500 | $7,756,898 | 0 | $0 |
1. Quest Diagnostics Inc (DGX)
2. Vertex Pharmaceuticals Inc / Ma (VRTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-29 | DGX | Sale | 1,644 | 105.61 | 173,622 |
| 2017-08-04 | DGX | Sale | 296 | 106.66 | 31,571 |
| 2017-07-27 | DGX | Sale | 1,304 | 108.73 | 141,782 |
| 2016-08-03 | DGX | Option Ex | 6,641 | 69.88 | 464,079 |
| 2016-08-03 | DGX | Sale | 6,345 | 85.63 | 543,296 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-14 | VRTX | Option Ex | 53,604 | 88.78 | 4,759,231 |
| 2025-11-13 | VRTX | Sale | 19,688 | 440.63 | 8,675,221 |
| 2025-11-14 | VRTX | Sale | 53,604 | 441.22 | 23,650,996 |
| 2025-11-13 | VRTX | Option Ex | 19,688 | 91.05 | 1,792,592 |
| 2024-08-30 | VRTX | Sale | 3,784 | 499.00 | 1,888,216 |
| 2024-02-14 | VRTX | Sale | 4,356 | 419.04 | 1,825,338 |
| 2024-02-15 | VRTX | Sale | 4,655 | 419.16 | 1,951,189 |
| 2024-02-13 | VRTX | Sale | 737 | 419.13 | 308,898 |
| 2024-02-12 | VRTX | Sale | 2,656 | 419.81 | 1,115,002 |
| 2023-12-13 | VRTX | Sale | 13,354 | 399.80 | 5,338,929 |
| 2023-10-16 | VRTX | Sale | 12,962 | 374.00 | 4,847,788 |
| 2023-05-05 | VRTX | Sale | 879 | 349.84 | 307,509 |
| 2023-05-08 | VRTX | Sale | 1,125 | 349.00 | 392,625 |
| 2023-05-02 | VRTX | Sale | 6,450 | 351.05 | 2,264,253 |
| 2023-05-03 | VRTX | Sale | 4,508 | 350.45 | 1,579,815 |
| 2022-07-25 | VRTX | Sale | 132,079 | 281.39 | 37,165,181 |
| 2022-07-25 | VRTX | Option Ex | 60,342 | 91.05 | 5,494,139 |
| 2022-04-13 | VRTX | Sale | 15,789 | 289.04 | 4,563,652 |
| 2020-06-30 | VRTX | Sale | 32,792 | 287.72 | 9,434,914 |
| 2020-05-12 | VRTX | Option Ex | 88,532 | 132.75 | 11,753,065 |
| 2020-05-12 | VRTX | Sale | 94,370 | 283.07 | 26,713,127 |
| 2020-05-07 | VRTX | Option Ex | 88,534 | 132.75 | 11,753,331 |
| 2020-05-07 | VRTX | Sale | 94,369 | 270.02 | 25,481,517 |
| 2020-05-05 | VRTX | Option Ex | 88,537 | 132.75 | 11,753,729 |
| 2020-05-05 | VRTX | Sale | 94,372 | 269.77 | 25,458,640 |
| 2020-02-25 | VRTX | Sale | 10,550 | 233.73 | 2,465,893 |
| 2020-02-18 | VRTX | Sale | 11,685 | 243.71 | 2,847,798 |
| 2020-02-11 | VRTX | Sale | 47,523 | 245.92 | 11,686,761 |
| 2019-11-19 | VRTX | Option Ex | 96,534 | 120.52 | 11,633,795 |
| 2019-11-19 | VRTX | Sale | 96,534 | 211.53 | 20,419,837 |
| 2019-11-15 | VRTX | Option Ex | 5,000 | 120.52 | 602,575 |
| 2019-11-15 | VRTX | Sale | 5,000 | 210.00 | 1,050,000 |
| 2019-11-18 | VRTX | Option Ex | 4,434 | 120.52 | 534,363 |
| 2019-11-18 | VRTX | Sale | 4,434 | 210.00 | 931,140 |
| 2019-10-22 | VRTX | Option Ex | 107,831 | 120.52 | 12,995,252 |
| 2019-10-22 | VRTX | Sale | 107,831 | 190.00 | 20,487,890 |
| 2019-06-18 | VRTX | Option Ex | 56,030 | 77.31 | 4,331,679 |
| 2019-06-18 | VRTX | Sale | 56,030 | 175.72 | 9,845,591 |
| 2019-05-24 | VRTX | Option Ex | 113,432 | 77.31 | 8,769,427 |
| 2019-05-24 | VRTX | Sale | 113,432 | 175.10 | 19,861,943 |
| 2019-05-06 | VRTX | Sale | 33,058 | 175.01 | 5,785,645 |
| 2019-05-06 | VRTX | Option Ex | 33,058 | 77.31 | 2,555,713 |
| 2019-02-19 | VRTX | Sale | 20,997 | 187.61 | 3,939,310 |
| 2019-02-04 | VRTX | Sale | 32,250 | 186.43 | 6,012,206 |
| 2018-06-22 | VRTX | Option Ex | 106,500 | 83.36 | 8,877,840 |
| 2018-06-22 | VRTX | Sale | 140,211 | 160.00 | 22,433,760 |
| 2018-01-16 | VRTX | Sale | 99,563 | 157.65 | 15,695,907 |
| 2018-01-16 | VRTX | Option Ex | 99,563 | 46.92 | 4,671,993 |
| 2017-12-11 | VRTX | Sale | 125,000 | 141.81 | 17,726,875 |
| 2017-07-31 | VRTX | Sale | 11,063 | 153.18 | 1,694,630 |
| 2017-07-31 | VRTX | Option Ex | 11,063 | 45.11 | 499,051 |
| 2017-07-19 | VRTX | Option Ex | 184,374 | 46.92 | 8,651,749 |
| 2017-07-19 | VRTX | Sale | 184,374 | 161.00 | 29,684,214 |
| 2017-07-21 | VRTX | Sale | 32,250 | 159.86 | 5,155,420 |
| 2017-06-02 | VRTX | Option Ex | 147,101 | 41.91 | 6,165,738 |
| 2017-06-02 | VRTX | Sale | 147,101 | 129.50 | 19,049,579 |
| 2017-04-28 | VRTX | Sale | 157,200 | 119.50 | 18,785,400 |
| 2017-04-28 | VRTX | Option Ex | 140,034 | 33.16 | 4,644,227 |
| 2017-02-13 | VRTX | Sale | 23,904 | 88.03 | 2,104,388 |
| 2016-02-03 | VRTX | Sale | 9,834 | 91.44 | 899,201 |
| 2015-11-18 | VRTX | Sale | 16,125 | 130.00 | 2,096,250 |
| 2015-10-30 | VRTX | Sale | 16,125 | 125.24 | 2,019,462 |
| 2015-02-18 | VRTX | Sale | 32,250 | 112.91 | 3,641,186 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leiden Jeffrey M (Executive Chairman of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.